Detalhe da pesquisa
1.
Infliximab therapy together with tyrosine kinase inhibition targets leukemic stem cells in chronic myeloid leukemia.
BMC Cancer
; 19(1): 658, 2019 Jul 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31272418
2.
Targeting cytokine-induced leukemic stem cell persistence in chronic myeloid leukemia by IKK2-inhibition.
Haematologica
; 108(4): 1179-1185, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36453102
3.
Myelofibrosis at diagnosis is associated with the failure of treatment-free remission in CML patients.
Front Pharmacol
; 14: 1212392, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37469867
4.
The Unfolded Protein Response Is a Major Driver of LCN2 Expression in BCR-ABL- and JAK2V617F-Positive MPN.
Cancers (Basel)
; 13(16)2021 Aug 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34439364
5.
Stem cell persistence in CML is mediated by extrinsically activated JAK1-STAT3 signaling.
Leukemia
; 33(8): 1964-1977, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30842608
6.
Identification of a Novel High Yielding Source of Multipotent Adult Human Neural Crest-Derived Stem Cells.
Stem Cell Rev Rep
; 14(2): 277-285, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29243108